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A B S T R A C T
5-fluorouracil (5-FU) is a chemotherapeutic agent used for treatment of solid tumors.
Cardiotoxicity is a major complication of 5-FU therapy. Therefore, the aim of the present
study was to evaluate the possible cardioprotective potency of Lepidium sativum seed powder
(LS) against 5-FU-induced cardiotoxicity and oxidative stress in albino rats. The rats were
divided into three groups. Rats in the control group received saline daily for 8 days only.
Rats in FU-treated group received saline orally for 8 days, then I.P. injected with 5-FU
(150 mg\kg B.W) on the 5th day. Rats in LS-treated group were orally dosed with LS
(550 mg\kg B.W\day) for 8 days, and on the 5th day rats were administrated with the same
previous dose of 5-FU. 5-FU induced cardiotoxicity was assessed by a significant increase
in serum concentrations of cTnI, CK-MB, lipid profile and a moderate elevation of cardiac
MDA. 5-FU significantly decreased serum HDL-c and GSH concentration in cardiac homog-
enate. Its administration also resulted in the release of some inflammatory markers such
as myeloperoxidase and Interleukin-1β (IL-1β). All 5-FU altered parameters were markedly
ameliorated by LS pre-co-post-treatment. Results of the present study suggest that LS has
a significant effect on the protection of the heart against 5-FU-induced cardiotoxicity through
maintaining the antioxidant and anti-inflammatory activities.
© 2016 Beni-Suef University. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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1. Introduction
5-fluorouracil (5-FU) is an antimetabolite fluoropyrimidine
analog of the nucleoside pyrimidine with antitumor activity.
5-FU is widely used systemically for breast, gastrointestinal,
pancreatic and skin cancers (Rossi, 2013). The main mecha-
nism of action is interfering with DNA synthesis and mRNA
transcription. However, cardiotoxicity is one of the most im-
portant associated side effects resulting from its nonspecific
cytotoxicity in cancer cells (Álvarez et al., 2012; Carrillo et al.,
2015). Clinical cardiac toxicities associated with intravenous
infusion of 5-FU covers a wide range of manifestations like
angina, myocardial ischemia, congestive heart failure, myo-
cardial infarction, pulmonary edema, and sudden death (Polk
et al., 2014; Sorrentino et al., 2012; Tsavaris et al., 2002). Recent
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studies showed that the incidence of 5-FU-induced
cardiotoxicity was in the range of 0–20% (Polk et al., 2014), and
highlighted an increased risk of toxicity during the adminis-
tration of higher doses of 5-FU with continuous infusion and
not bolus administration. After administration, 5-FU follows
different metabolic fates; more than 80% of the dose is inac-
tivated by hepatic biotransformation, about 15–20% is excreted
in the urine and only a small fraction remains available to exert
its antineoplastic activity (Casale et al., 2004).
Differentmechanisms of 5-FU induced cardiotoxicity are pro-
posed, including direct drug or drug metabolite-mediated toxic
action on myocytes (Mizuno et al., 1995), coronary vaso-
spasm and thrombogenic effects (Bertolini et al., 2001). 5-FU
induces the endothelial damage and extravasation of blood with
the drug into cardiac tissue resulting in an inflammatory re-
action andmyofibril necrosis (Bertolini et al., 2001; Kumar et al.,
1995). Another theory has suggested cardiotoxic impurities in
the 5-FU formulation (fluoroacetaldehyde, generated in the al-
kaline solution of fluorouracil during storage, which may be
converted to a cardiotoxic agent, fluoroacetate) (Arellano et al.,
1998; Becker et al., 1999). Fluoroacetate enters the Krebs’ cycle
and converts into fluorocitrate, which inhibits the enzyme
aconitase (Keller et al., 1996) causing citrate accumulation, dis-
ruption of the tricarboxylic acid cycle and severe impairment
of energy production within themyocytes (Gradishar and Vokes,
1990). The pathogenesis of 5-FU induced cardiotoxicity may
involve cellular damage due to the oxidative stress and the in-
duction of apoptosis (Rashid et al., 2014). Accordingly,
therapeutic interventions having antioxidant activity may be
effective against oxidative stress associated with cardiovas-
cular diseases.
Lepidium sativum (LS) is locally known as ‘hub arachad’ be-
longing to family Brassiaceae. Chemically, the plant seeds and
leaves contain flavonoids and isothiocynates glycosides, essen-
tial oils, carbohydrates, proteins, fatty acids, β-carotene and
vitamins like riboflavin, niacin and ascorbic acid (Yadav et al.,
2010). The seeds are consumed in salad and as a spice (Maier
et al., 1998). The plant leaves and seeds have been used in tra-
ditional medicine.The plant is reported to have hypoglycemic,
antihypertensive, diuretic (Jouad et al., 2001; Patel et al., 2009)
hemagglutinating, fracture healing (Eddouks et al., 2005; Yadav
et al., 2011), anti-inflammatory (Raval et al., 2013), hepato-
protective (Abuelgasim et al., 2008; Al-Asmari et al., 2015), an-
tioxidant (Agarwal and Verma, 2011; Zia-Ul-Haq et al., 2012) and
anti-carcinogenic activities (Maghrani et al., 2005).
The present study was designed to investigate the cardio-
protective effect of LS against 5-FU-induced cardiotoxicity in
rats by studying some biochemical cardiac injury markers, an-
tioxidant defense system, serum lipid profile and inflammatory
markers.
2. Materials and methods
2.1. Chemicals
5-fluorouracil was obtained from ACDIMA International (AiT)
Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Reduced glu-
tathione (GSH), malondialdehyde (MDA) and nitric oxide (NO)
commercial kits were purchased from Bio-diagnostic Company
for research kits, Egypt. Triacylglycerol (TAG), total choles-
terol (TC) and HDL-cholesterol commercial diagnostic kits were
purchased from Spinreact Company, Spain. RatTroponin I (cTnI)
(Catalog number KT-639), rat Creatinine kinase-MB isoenzyme
(CK-MB) (Catalog number KT-12247) and rat myeloperoxidase
(Catalog number KT-60345) immunoassay kits were pur-
chased from Kamiya Biomedical Company, USA. Rat Interleukin-
1β (IL-1β) (Catalog number K 0331212) ELISA kit was purchased
from Komabiotech Company, Korea.
2.2. Plant material
Lepidium sativum L. seeds (known as garden cress) (LS) were
obtained fromAgricultural Research Center, Egypt. Garden cress
seeds were dried and ground to powder. The suspension of
Lepidium seed powder was made with a sufficient quantity
of distilled water by a dose of 550 mg/kg B.W (Raval and
Ravishankar, 2010). It was administered through the oral route
with the help of a gastric gavage. Other non-mentioned chemi-
cals used in the present study were of the highest analytic grade
and purchased from Sigma-Aldrich Company, USA.
2.3. Animals and experimental design
Thirty adult male albino Sprague–Dawley rats (120–150g) were
provided by the Helwan farm of laboratory animals Cairo, Egypt.
Rats were kept in standard cages at room temperature (25 ± 2 °C)
with a 12: 12 h dark-light cycle and humidity (70%). All animals
were allowed free access to water and fed with uniformly basal
diet. All experimental procedures were conducted in accor-
dance with the guide for the care and use of laboratory animals
and in accordance with the local Animal Care and Use Com-
mittee. After acclimatization, rats were randomly divided into
3 groups (n = 10). Animals in the control group received only
saline daily for 8 days by oral gavage. Animals in FU-treated
group received saline orally for 8 days, then were given a single
dose of 5-FU (150 mg\kg B.W\I.P injection on the 5th day)
(Blijham, 1991). Animals in LS-treated group received a sus-
pension of LS seed powder (550 mg\kg\day) (Raval and
Ravishankar, 2010) orally for 8 days and were injected with a
single dose of 5-FU (150 mg\kg B.W\I.P) on the 5th day.
2.4. Blood sampling and tissue preparation
Blood samples were collected 24 hours after the last dose, and
all rats were sacrificed by cervical decapitation. The obtained
sera were monitored for lipid profile, cTnl and CK-MB activ-
ity. Heart tissues were excised after dissection of the animals
and designated for biochemical analysis. The excised heart
tissue (0.5 g) was homogenized in ten volumes of ice cold phos-
phate buffer (pH:7) until a uniform suspension was obtained.
The homogenate was then centrifuged at 20,000 × g for 10 min
at 4 °C using high speed cooling centrifuge. The clear super-
natant was used for the assay of GSH,MDA, NO,MPO and IL-1β.
2.5. Biochemical assays
2.5.1. Serum analysis
Serum cardiac markers (CK-MB and cTnI) were measured ac-
cording to instruction of diagnostic kits. Serum lipid profile (TAG,
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TC and HDL-cholesterol) were assayed spectrophotometri-
cally with the enzymatic colorimetric method described by
authors (Burstein et al., 1970; Fossati and Principe, 1982;
Richmond, 1973), respectively. VLDL-cholesterol was calcu-
lated as TG/5 while LDL-cholesterol was calculated by the
formula [LDL-c = total cholesterol-HDL-c-VLDL-c] according to
Fruchart (1982). Atherogenic index was calculated by the equa-
tion (LDL-c/HDL-c) described by Castelli and Levitar (1977).
2.5.2. Heart tissue analysis
Oxidant\antioxidant status in heart tissues includes GSH con-
centration was determined according to the method of Beutler
et al. (1963). Lipid peroxides as MDA concentration were mea-
sured according to themethod of Satoh (1978). NO concentration
was determined by using biochemical method of Montgomery
and Dymock (1961). Pro-inflammatory cytokines in cardiac tissue
(MPO and IL-1B) were estimated according to instruction of di-
agnostic kits.
2.6. Statistical analysis
Statistical analysis was carried out using Graph Pad In stat soft-
ware (version 3, ISS-Rome, Italy). One way analysis of variance
(ANOVA) test followed by Tukey–Kramer (TK) multiple com-
parison post test were used. The values are expressed as
mean ± standard error (SE). The p values below 0.05 were con-
sidered statistically significant.
3. Results
Results of cardiac biomarkers were reported in Figs. 1 and 2
and showed a significant increase in serum concentrations of
cTnl (Fig. 1) and CK-MB (Fig. 2) in FU-treated group in com-
parison to control group. This elevation was significantly
decreased in LS-treated group, indicating the cardioprotective
role of the plant.
Table 1 represented the effects of 5-FU and LS treatment on
serum lipid profile, includingTAG,TC, HDL-c,VLDL-c LDL-c con-
centrations in different rat groups. 5-FU treatment significantly
increased the serum TAG and TC levels in FU-treated group in
comparison to control group indicating hypertriglyceridemia and
hypercholesterolemia. Serum LDL-c and VLDL-c concentra-
tions are significantly increased while the serum HDL-c
concentration is significantly decreased in FU-treated group in
comparison to control group. Pre-co-post-treatment with LS sig-
nificantly improved the tested parameters. Fig. 3 illustrated the
mean ratio of the atherogenic index (LDL-C/HDL-C) in different
treated groups. Atherogenic index is a stronger risk predictor
of cardiovascular. Results showed a significant increase in this
ratio in the FU-treated group which was significantly de-
creased by LS treatment.
Table 2 represented the concentrations of cardiac homog-
enate MPO, IL-1β, GSH, MDA and NO in different groups. It
showed a significant increase in inflammatory markers such
as myocardial IL-1β and MPO activity and a significant de-
crease in GSH concentration in the FU-treated group when
compared to control rats. LS treatment reversed the results of
these tested parameters. However, cardiac MDA and NO con-
centrations were non-significantly increased in the FU-
treated group in comparison to control group and were non-
significantly decreased in the LS-treated group.
4. Discussion
5-fluorouracil is a commonly prescribed chemotherapy for a
wide range of solid tumors.When elemental fluorine is reacted
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Fig. 1 – Serum troponin I (cTnI) concentration in different
treated groups.
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Fig. 2 – Serum CK-MB activity in different treated groups.
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with uracil, 5-fluorouracil is produced. Fluorouracil and its me-
tabolites have a number of various mechanisms of action. It
acts principally as a thymidylate synthase (TS) inhibitor. Fol-
lowing its administration, 5-FU is rapidly metabolized to
5-fluordeoxyuridine 5’monophosphate (FdUMP) which com-
petitively binds to TS and blocks the methylation of uracil
toward thymine which is required for DNA replication. So the
cancerous cells undergo cell death via thymine-less death
(Longley et al., 2003). Moreover, 5-FU is phosphorylated to tri-
phosphate (F-UTP) and incorporated into RNA instead of uracil,
thus blocking their transcription and stopping the growth of
cancerous cells. Cytotoxic effects are also deriving from
incorporation of FdUTP into DNA as well as F-UTP and
5-fluorocytosine into RNA. These metabolites are thought to
influence calcium channel dependent membrane function, to
interfere with mitochondrial phosphate metabolism, to alter
contractile proteins, to cause oxidative damage and release of
vasoactive substances like histamine and catecholamines, and
lead to autoimmune mechanisms (Cianci et al., 2003).
The mechanisms of 5-FU-induced cardiotoxicity are hem-
orrhagic infarction, myocardial inflammatory reaction with
interstitial fibrosis; arterial endothelial injury followed by throm-
bosis (Bertolini et al., 2001); increased metabolism leading to
depletion of ATP, increased levels of superoxide anion and a
decreased antioxidant capacity; arterial vasoconstriction and
altered plasma levels of substances involved in coagulation and
fibrinolysis (Dechant et al., 2012). Oxidative stress causes cel-
lular damage, coronary artery spasm and the decreased affinity
of RBCs to transfer oxygen, resulting in myocardial ischemia,
cardiac arrest and sudden death (Polk et al., 2014).
Myocardium contains high concentrations of diagnostic
markers for myocardial infarction and once metabolically
damaged, it releases its content into the extracellular fluid
(Farvin et al., 2004; Upaganlawar et al., 2009). Serum creati-
nine kinase (CK) and troponins are some of these markers.
Assay of the CK-MB isoenzyme activity in serum is an impor-
tant diagnostic indicator owing to its marked excess in
myocardial tissue and its consequent sensitivity. The in-
creased activity of serum CK-MB isoenzyme reflects the
alterations in the plasma membrane integrity and permeabil-
ity (Farvin et al., 2004). Cardiac troponin I (cTnI) is a cell-
structural protein specific to myocardial tissue. cTnI is sensitive
and specific biochemical marker of myocardial cell necrosis and
has been considered as the gold standardmarker for acutemyo-
cardial infarction and drug-induced cardiotoxicity (Gaze and
Collinson, 2005). In the present study, 5-FU treated rats showed
a significant elevation in the activity of serum CK-MB and cTnI
level (Figs. 1 and 2), which indicated 5-FU induced myocar-
dial necrotic damage and the leakiness of the plasma
membrane. LS treatment resulted in lower activity of the CK-
MB and cTnI level in serum. It was demonstrated that LS could
maintain membrane integrity, thereby limiting the leakage of
these biomarkers.
Hyperlipidemia plays an important role in cardiovascular
diseases and the development of atherosclerosis (Hassarajani
et al., 2007; Neil et al., 1990).A significant elevation in the serum
TC, TAG, VLDL-c and LDL-c fractions along with a decrease in
HDL-c were observed in 5-FU treated rats compared to control
rats (Table 1). These observed changes concerning lipid profile
come in agreement with Abdel-Hamid et al. (2011) and could
be attributed to the enhanced lipid synthesis via cardiac cyclic
Table 1 – Serum TAG, cholesterol, HDL-c, VLDL-c, LDL-c concentrations in different treated groups.
TAG (mg/dl) Cholesterol (mg/dl) VLDL-c (mg/dl) HDL-c (mg/dl) LDL-c (mg/dl)
Control 64.39 ± 4.99a 95.05 ± 5.09a 12.88 ± 1.01a 47.62 ± 2.60a 34.55 ± 2.64a
FU-treated 145.2 ± 8.59b 214.1 ± 17.12b 29.04 ± 1.72b 25.43 ± 1.65b 159.7 ± 13.15b
LS-treated 97.14 ± 4.54c 136.2 ± 8.68a 19.43 ± 0.91c 41.77 ± 2.51a 75.01 ± 6.27c
Means with different superscript letters are significantly different at p < 0.05. The data are presented as means ± S.E.
Table 2 – Cardiac concentrations of MPO, IL-1 β, GSH, MDA and NO in different treated groups.
MPO (u/100 mg tissue) IL-1β (pg/mg) GSH (mg/g tissue) MDA (nmol/g tissue) NO (μ mol/L)
Control 0.410 ± 0.064a 44.60 ± 0.95a 40.24 ± 3.10a 89.70 ± 6.54 41.15 ± 4.27
FU-treated 1.503 ± 0.169b 82.90 ± 0.81b 23.12 ± 2.04b 104.3 ± 6.74 48.50 ± 3.66
LS-treated 0.817 ± 0.023a 50.40 ± 2.15a 33.27 ± 1.50a 93.40 ± 3.81 42.18 ± 3.61
Means with superscript letters are significantly different at p < 0.05. The data are presented as means ± S.E.
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Fig. 3 – The mean ratio of the atherogenic index (LDL-c/
HDL-c) in different treated groups.
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adenosine monophosphate (Paritha and Devi, 1997). Hyper-
cholesterolemia and hypertriglyceridemia are mainly related
to cardiac ischemia (Jackson and Beaglehole, 1995). The ath-
erogenic effect of 5-FU as the mean ratio of LDL-c/HDL-c was
significantly increased in FU-treated rats (Fig. 3). The higher
atherogenic index, the higher is the risk of the cardiovascu-
lar disease (Karthikeyan et al., 2007).Atherogenic index indicates
the deposition of foam cells or fatty infiltration of lipids in heart,
coronaries, aorta, liver and kidneys.
The treatment with LS successfully restored the altered
serum parameters as shown in Table 1. Halaby et al. (2015) re-
ported that a diet supplemented with 5% and 10% LS seed
powder improved the altered lipid profile in cisplatin-injected
rats. Moreover, treatment with flavonoid and sapogenin
extracts of LS lowered TC, TAG, LDL-c and AI values in hyper-
lipidemic rats (Shukla et al., 2015). Also, hypolipidemic and
hypocholesterolemic effects of LS were mentioned by Umesha
and Naidu (2012) and Althnaian (2014).The hypolipidemic effect
of LS might be due to inhibition of absorption and enhanced
excretion of lipids through the gastrointestinal tract (Chauhan
et al., 2012). The hypocholesterolemic effect of LS might be at-
tributed to inhibition of cholesterol biosynthesis via inhibition
of HMG-CoA reductase, the rate-limiting enzyme that medi-
ates the first step in cholesterol biosynthesis (Althnaian, 2014).
The increased levels of the cardio protective lipoprotein; HDL-c
after administration of LS concluded that the plant has a potent
cardioprotective effect, and this effect may be due to the in-
creased activity of lecithin: cholesterol acyl transferase (LCAT),
an enzyme which plays a key role in incorporating the free cho-
lesterol into HDL-c which is then catabolized by the hepatocytes
(Shukla et al., 2015).
Oxidative stress is an overproduction of reactive oxygen
species (ROS) with a deficiency of enzymatic and non-enzymatic
antioxidants (Valko et al., 2007). Recent studies have sug-
gested that the 5-FU-induced cytotoxicity is linked to the
enhanced ROS formation as 5-FU increased intracellular levels
of superoxide anion (O-2) (Afzal et al., 2012). As a conse-
quence, the triggering of apoptotic program and cardiomyocyte
damage were occurring (Lamberti et al., 2012). However, the
exact molecular mechanisms of 5-FU cardiotoxicity have not
yet been completely understood. These ROS may attack any
type of molecules, but their main target appears to be polyenoic
fatty acids within membranes forming peroxyl radicals.These
radicals then attack adjacent fatty acids within membranes,
causing a chain reaction of lipid peroxidation (Priscilla and
Prince, 2009) and myocardial necrosis (Rajadurai and Prince,
2006). MDA is used as a marker of lipid peroxidation (Nielsen
et al., 1997). It was elevated in the hearts of guinea pig (Durak
et al., 2000) and rat (Eskandari et al., 2014) after 5-FU-treatment.
Moreover, Kinhult et al. (2003) suggested that the arterial en-
dothelial damage resulted from 5-FU therapy may be due to
the generation of ROS. These findings agreed with our results
as shown in Table 2 and indicate the occurrence of some
degrees of oxidative stress and myocardial damage during 5-FU
treatment.
Glutathione depletion is an indicator of oxidative stress. GSH,
a tripeptide, is one of the cellular non-enzymatic antioxidant
biomolecules. GSH has a direct antioxidant action by react-
ing with superoxide radicals, peroxy radicals and singlet oxygen
followed by the formation of oxidized GSSG and other disulfides.
In addition, it has a role in drug detoxification (Meister, 1988).
When isolated cardiomyocytes were incubated with 5-FU, glu-
tathione depletion was progressing as a consequence of ROS
formation (Eskandari et al., 2014). In our experiment, the cardiac
GSH level was significantly decreased as shown in Table 2 after
5-FU administration. Hence, it is confirmed that the cytotoxic
mechanism of 5-FU is mediated via oxidative stress. LS has an
antioxidant effect (Halaby et al., 2015; Olorunnisola et al., 2012)
so it caused a significant elevation of the GSH level and a non-
significant decrease of the MDA concentration in cardiac
homogenate of LS-treated group. These results were parallel
with the data obtained by Behrouzian et al. (2014) and Doke
and Guha (2014).
Nitric oxide (NO) is an important signalingmessenger known
to play important roles in many physiological (such as host
defense and homeostasis) and pathological (such as inflam-
mation) conditions (Zhang et al., 2008). In mammalian cells,
NO is generated in the cells by the NADPH-dependent oxida-
tion of arginine to citrulline by the enzyme nitric oxide synthase
(NOS) (Laskin et al., 1994). Overflow of NO may contribute to
inflammatory reaction through nitrosation, oxidative damage,
and enhanced release of inflammatory cytokines (Kanwar et al.,
2009). Several studies have shown action of 5-FU on the pro-
duction of NO (Matthews et al., 2001). Jung et al. (2002) suggested
the efficacy of 5-FU to block NO production through the inac-
tivation of IκB kinase in stomach cancer cells.While, Leitão et al.
(2007) suggested an important role of NO in the pathogenesis
of oral mucositis induced by 5-FU. In the present study, the 5-FU
administration showed no significant change of NO level, which
may be attributed to the formation of peroxynitrite by the re-
action of NO with generated superoxide radicals (Gandhi et al.,
2009).
Myeloperoxidase, an enzyme that is associated with the neu-
trophils, has been studied to form an index of the neutrophils
infiltration into inflamed tissue. Myeloperoxidase, a green he-
moprotein enzyme can use H2O2 generated by NADPH oxidase
to oxidize halides (Cl-, Br- and I-) to their corresponding
hypohalous acids (an additional class of active oxygen me-
tabolite) (Kettle et al., 1997). MPO generates different reactive
oxidants and diffusible radical species that are capable of both
initiating lipid peroxidation (Zhang et al., 2002) and stimulat-
ing post-translational modifications to target proteins, including
halogenation, nitration, and oxidative cross-linking (Heinecke,
2003; Podrez et al., 2000). Consequently, it is linked to both in-
flammation and oxidative stress. In the present study, the
significant increase in myocardial MPO activity is an indica-
tive of 5-FU-induced inflammation of myocardial tissue and
neutrophil infiltration. Restored levels of myocardial inflam-
matory markers in LS-treated group, indicated that the LS
suppressed the neutrophil infiltration and inflammatory
cytokine release to the injured myocardium.
Interleukin-1β (IL-1β) is an important pro-inflammatory
cytokines with a relevant role in the inflammatory disorders.
IL-1β is produced by monocytes,macrophages, endothelial cells
and fibroblasts (Dung et al., 2009). Okamoto et al. (1998) and
Curra et al. (2013) indicated that 5-FU is a potent inducer of
several types of cytokines, including IL-1β. This was achieved
in our results reported in Table 2 that showed a significant in-
crease in IL-1β concentrations in cardiac homogenate of FU-
treated rats in comparison to control ones.The increased MPO
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and IL-1β concentrations in cardiac homogenate indicate the
inflammatory effect of 5-FU (Soares et al., 2011). LS amelio-
rated that effect as it significantly decreased the concentration
of MPO and IL-1β in the LS-treated group due to its anti-
inflammatory activity.
Restored levels of myocardial MDA, GSH, MPO and IL-1β by
LS Administration may be attributed to its high content in an-
tioxidants (vitamin C, E, carotenoids, polyphenols and
flavonoids) (Donno et al., 2013; Lee et al., 2013) and its anti-
inflammatory activities (Calder, 2006; Lopez-Garcia et al., 2004).
In this respect, gas chromatography–mass spectrometry analy-
sis of LS showed the presence of alpha-linolenic acid (C18:3)
which has an anti-inflammatory activity (Al-Asmari et al., 2015).
The role of alpha linolenic acid is to downregulate the gene
expression of inflammatory cytokines such as IL-6, IL-1β and
TNF-α (Zhao et al., 2007).
5. Conclusion
Our results confirmed the existence of cardiotoxicity due to
5-FU therapy, which was indicated by an elevation of serum
cardiac cTnI, CK-MB, altered lipid profile and atherogenic index
with enhanced oxidative stress and the release of some in-
flammatory markers. It can be concluded that LS seed exerts
cardioprotective activity that could be partly contributed by its
antioxidant and anti-inflammatory activities. So, Lepidium
sativum can be considered a candidate to protect against
cardiotoxicity commonly encountered with 5-FU treatment.
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